A team at Portland State University is leading research on a new drug showing promise to treat one of the deadliest diseases ...

The first malaria drug for newborn babies and those weighing less than 11 pounds has been approved by Swiss medical authorities in a move that could fill a treatment gap for some of those most ...

WHO prequalification of Coartem Baby means newborns can be safely treated rather than using medication for older children ...

WEST LAFAYETTE, Ind. — A cancer drug repurposed to treat malaria has been shown to be nearly 100% effective in helping defeat the disease in just three days, according to the results of a Phase 2 ...

The first-ever treatment for malaria in young babies and infants has been approved. On Tuesday, Novartis announced it had received approval for the treatment, Coartem Baby (known as Riamet Baby in ...

Swiss medical authorities have approved the first drug suitable to treat malaria in babies and very young children. Eight African countries that participated in clinical trials are now poised to ...

NEW YORK — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs. Switzerland-based Novartis ...

An experimental antibody treatment prevented malaria in the majority of participants in a small but important new study, providing a measure of hope in the effort to lower the burden of the disease ...

A surge in malaria cases in Zimbabwe is exposing fragile health systems and growing treatment shortages in rural areas.